Inhalator

European patent · EP2865403 · In force

Register entry

Publication number
EP2865403
Application number
EP14198936
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 13, 2012
Published
Apr 29, 2015
Granted
Jun 15, 2016
Protection ends at the latest
Mar 12, 2032
Next annual fee due
Mar 31, 2027
IPC classes
A61M 15/00 (2006.01)
Priority
US 201161452763 P 15.03.2011
Divided from
EP12711598
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Jun 15, 2016

    Granted

    Published in Swissreg on 15.06.2016

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

Hosemann, Michael

Cambridge, Cambridgeshire CB40DW, GB

Phillips, Desmond

Cambridge, Cambridgeshire CB40DW, GB

Ramble, David

Cambridge, Cambridgeshire CB40DW, GB

Reynolds, Sean

West Sussex, GU29 9AZ, GB

Vernon-Harcourt, Edward

West Sussex, Bn44 3 LG, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.